Pacibekitug is an investigational monoclonal antibody developed by Tourmaline Bio, Inc., through a license from Pfizer, targeting interleukin-6 (IL-6) for the treatment of inflammatory conditions.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.